Our Projects

Schistosomiasis (Bilharzia) Program:The Nyange Schistosomiasis program covers research and interventions. Some of the interventions include mass drug administration and vector control. For details refer to the WHO Factsheet.

Lymphatic Filariasis (Commonly referred to as Elephantiasis) Program:The Nyange Lymphatic Filariasis interventions include mass drug administration and vector control. For details refer to the WHO Factsheet.

Podoconiosis:Podoconiosis (nonfilarial elephantiasis), a disease of the lymphatic vessels of the lower extremities that is caused by chronic exposure to irritant soils. For details refer to the WHO Factsheet.

Onchocerciasis (River Blindness):The Nyange Onchocerciasis program covers research and interventions. Some of the interventions include mass drug administration and vector control. For details refer to the WHO Factsheet.

Malaria:Malaria is a life-threatening disease spread from a person to another person by some types of mosquitoes. It is mostly transmitted in tropical countries. It is preventable and curable. The infection is caused by a parasite and does not spread from person to person. For details refer to the WHO Factsheet.

Tuberculosis (TB):It is a bacterial disease that is transmissible through air. It attacks all the body parts, but lung TB is the most widespread. Tuberculosis (TB) is a major health challenge in Uganda, and the country is one of the world's high-burden countries. In 2022, the World Health Organization (WHO) estimated that 94,000 people in Uganda had TB, which is 198 cases per 100,000 population. TB mortality was estimated at 1,900 among HIV-negative persons, with an additional 2,800 deaths among people living with HIV (PLHIV). For details refer to the WHO Factsheet.

Leprosy (Hansen disease):The disease is caused by slow-growing bacteria called Mycobacterium leprae and Mycobacterium lepromatosis. The disease can affect the nerves, skin, eyes, and lining of the nose. Leprosy is endemic in Uganda, and while it was eliminated as a public health problem in 1994, new cases are still reported. Prevention of spread is early diagnosis and adherence to treatment. For details refer to the WHO Factsheet.